JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Even-Sapir, E.
Right arrow Articles by Israel, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Even-Sapir, E.
Right arrow Articles by Israel, O.

The New Technology of Combined Transmission and Emission Tomography in Evaluation of Endocrine Neoplasms

Einat Even-Sapir, Zohar Keidar, Jonathan Sachs, Ahuva Engel, Lise Bettman, Diana Gaitini, Luda Guralnik, Nahum Werbin, Galina Iosilevsky and Ora Israel

Departments of Nuclear Medicine and Diagnostic Radiology, Rambam Medical Center, Haifa; The Bruce Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, Haifa; and Departments of Nuclear Medicine and Surgery A, Tel-Aviv Sourasky Medical Center, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel



View larger version (54K):

[in a new window]
  		FIGURE 1. SRS-TET in patient with neuroendocrine tumor. (A) Scintigrams show 2 foci of increased 111In-octreotide uptake in midabdomen. (B) TET images (CT, left column; SPECT, center column; fusion, right column) show precise localization of 2 sites of uptake in retroperitoneal, paravertebral region and show involvement of T12 and L1 vertebrae. MRI confirmed findings, and surgery for resection was canceled.

 


View larger version (51K):

[in a new window]
  		FIGURE 2. Sestamibi-TET in patient with ectopic parathyroid adenoma. (A) 99mTc-sestamibi scintigrams (early phase, left; late phase, right) show parathyroid adenoma located inferior to right lobe of thyroid, extending into right thorax. (B) TET images (CT, left column; SPECT, center column; fusion, right column) show precise posterior localization of adenoma in right paratracheal region. Surgical approach was planned according to these findings, and adenoma was removed.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.